Jointown Pharmaceutical Group Co Ltd (600998) — Capital Reinvestment Ratio
Jointown Pharmaceutical Group Co Ltd (600998) has a Capital Reinvestment Ratio of 0.53x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥528.22 Million) in capital expenditures (CN¥281.66 Million). See 600998 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jointown Pharmaceutical Group Co Ltd Capital Reinvestment Ratio (2007–2024)
This chart tracks Jointown Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 12 annual periods. Check Jointown Pharmaceutical Group Co Ltd (600998) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Jointown Pharmaceutical Group Co Ltd (2007–2024)
Year-by-year Capital Reinvestment Ratio for Jointown Pharmaceutical Group Co Ltd from 2007 to 2024. For live market cap and broader valuation context, see Jointown Pharmaceutical Group Co Ltd (600998) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.32x | CN¥3.08 Billion | CN¥975.42 Million | ▲ +44.3% |
| 2023 | 0.22x | CN¥4.78 Billion | CN¥1.05 Billion | ▼ -29.7% |
| 2022 | 0.31x | CN¥3.99 Billion | CN¥1.24 Billion | ▼ -22.2% |
| 2021 | 0.40x | CN¥3.46 Billion | CN¥1.39 Billion | ▼ -5.3% |
| 2020 | 0.42x | CN¥3.44 Billion | CN¥1.46 Billion | ▼ -1.8% |
| 2019 | 0.43x | CN¥2.77 Billion | CN¥1.19 Billion | ▼ -71.0% |
| 2018 | 1.49x | CN¥1.22 Billion | CN¥1.81 Billion | ▼ -44.3% |
| 2016 | 2.67x | CN¥431.26 Million | CN¥1.15 Billion | ▲ +15.3% |
| 2015 | 2.31x | CN¥435.96 Million | CN¥1.01 Billion | ▼ -47.8% |
| 2013 | 4.43x | CN¥138.47 Million | CN¥613.81 Million | ▲ +596.5% |
| 2008 | 0.64x | CN¥494.75 Million | CN¥314.90 Million | ▼ -85.7% |
| 2007 | 4.44x | CN¥65.95 Million | CN¥293.03 Million | — |